Sentences with phrase «by biopharmaceutical company»

The study is funded by the biopharmaceutical company Merck & Co., which makes pembrolizumab, or Keytruda.

In April 2011, TransMolecular's tumour - targeter was snapped up by biopharmaceutical company Morphotek, a US - based subsidiary of Japanese drug giant Eisai.

This constitutes a major cause of long - term sick leave and forced early retirement, placing a great financial burden on both individuals and healthcare systems.Despite extensive research programmes by biopharmaceutical companies and academia, there remains a need for treatments that are more effective and with fewer side - effects.

Not exact matches

By merging, Babcook says, «we can increase our probability of becoming an anchor company for Canada and a fully integrated biopharmaceutical company over the long term.»

Of 12 major, large - cap biopharmaceutical companies examined by Deloitte, the industry appears to be homing in on cancer therapies — and for a good economic reason.

Prior to Sucampo, he served as Chief Scientific Officer of Ambrx Inc., a clinical - stage biopharmaceutical company focused on the development of antibody - drug conjugates (ADCs) that was acquired by a consortium led by Fosun Pharmaceutical Group in 2015.

Biopharmaceutical company Parexel confirmed Tuesday morning it will be acquired by Pamplona Capital for $ 88.10 per share in cash, in a transaction valued at approximately $ 5 billion.

Both Price and Gottlieb were questioned on their intimate involvement with biopharmaceutical and health care companies by lawmakers; Price specifically was the subject of sharp ethics questions about his financial investments in medical firms that would also benefit from legislation he was pushing while serving in the House of Representatives.

Retailer Williams - Sonoma, biopharmaceutical company Medivation and bank Wells Fargo ranked as the companies with the most high - ranking positions held by women, researchers said.

Wth technology addressing skin microbial therapeutics, fertility science, chronic disease alleviation, post traumatic stress disorder treatments, and services for the biopharmaceutical and clinical research industries; the startups selected by Illumina will have access to the company's genomics and sequencing expertise, business coaching, lab and office space and an infusion of capital.

SOUTH SAN FRANCISCO, CA — July 25, 2017 — Kezar Life Sciences, a private, clinical - stage biopharmaceutical company developing novel small molecule therapeutics targeting the immunoproteasome and the protein secretion pathway, announced today that it has closed an oversubscribed Series B investment round of $ 50 million led by Cormorant Asset Management and Morningside Venture.

An online survey conducted by the Clinical Data Interchange Standards Consortium (CDISC) and CenterWatch1 with 750 respondents — including investigative site personnel (355), biopharmaceutical companies (211), service providers for the industry (146), and technology providers (38)-- yielded the following results:

In Texas the Ebola patient is now stable but in critical condition and being treated with brincidofovir, an oral medicine developed by Durham, N.C. — based biopharmaceutical company, Chimerix.

Since the initial Michigan trial, the liposomal transport system — developed by researchers at Vical, a San Diego - based biopharmaceutical company interested in gene therapy — has been altered in ways that are expected to make it safer, more effective and easier to administer.

Starting operations in 2012, iTeos Therapeutics is a clinical - stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by developing immunotherapies by design.

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc..

Press Release: Shire pays $ 825m to develop Renovo's scar - reduction remedy By Karen Attwood Thursday, 21 June 2007 Share Shire is to pay up to $ 825m (# 414m) to Renovo for the exclusive development and commercialisation rights to the biopharmaceutical company's groundbreaking scar - prevention drug.

SAN DIEGO and ALAMEDA, Calif., June 25, 2009 (GLOBE NEWSWIRE)-- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq: MNOV — News) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), and Avigen, Inc. (Nasdaq: AVGN — News), a biopharmaceutical company, today announced that they have confirmed their understanding of certain key terms for a proposed acquisition of Avigen by MediciNova that would combine the companies» broad neurological clinical development programs based on ibudilast (Avigen's AV - 411 and MediciNova's MN - 166).

FTSE 100 biopharmaceutical company Shire, led by director of legal strategy Claire Debney (pictured top left) and legal strategy manager Ama Zbarcea, has conducted an extensive sandbox exercise to engage its staff in the selection of a contract management system, as part of a much wider technologyled transformation programme.

Shire's CSO leads tech transformation programme FTSE 100 biopharmaceutical company Shire, led by chief strategy officer Claire Debney and legal strategy manager Ama Zbarcea, has conducted an extensive sandbox exercise to engage its staff in the selection of a contract management system, as part of a much wider technology - led transformation programme.

With a eight years of research & development experience in molecular biology and biochemistry, I desire to develop a career in biopharmaceutical industry by using my technical, scientific, leadership, problem solving and management skills to carry out lab bench work that meet the business goals of a cutting edge company.